The biology of human breast epithelial progenitors

Seminars in Cell and Developmental Biology

Volumn 23, Issue 5, 2012, Pages 606-612

  Raouf, Afshin ^a   Sun, Yujia ^a   Chatterjee, Sumanta ^a   Basak, Pratima ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bipotent progenitors; Hierarchy of human breast cells; Human breast progenitors; Luminal restricted progenitors; Myoepithelial restricted progenitors

Indexed keywords

ESTROGEN; MESSENGER RNA; PROGESTERONE; TRANSCRIPTION FACTOR; UNTRANSLATED RNA;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST EPITHELIUM PROGENITOR CELL; CANCER RESEARCH; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; GENE MUTATION; HUMAN; LONGEVITY; NONHUMAN; ONCOGENE; PHENOTYPE; REVIEW; STEM CELL;

EID: 84863858993     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.04.009     Document Type: Review

References (82)

1. Howard B.A., Gusterson B.A. Human breast development. Journal of Mammary Gland Biology and Neoplasia 2000, 5(April (2)):119-137.
2. Russo J., Russo I.H. Development pattern of human breast and susceptibility to carcinogenesis. European Journal of Cancer Prevention 1993, 2(November (3)):85-100.
3. Russo J., Russo I.H. Development of the human breast. Maturitas 2004, 49(September (1)):2-15.
4. Rosen J.M. Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression. Breast Disease 2003, 18:3-9.
5. Potten C.S., Watson R.J., Williams G.T., Tickle S., Roberts S.A., Harris M., et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. British Journal of Cancer 1988, 58(August (2)):163-170.
6. Soderqvist G., Isaksson E., von Schoultz B., Carlstrom K., Tani E., Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. American Journal of Obstetrics and Gynecology 1997, 176(January (1 Pt 1)):123-128.
7. Vogel P.M., Georgiade N.G., Fetter B.F., Vogel F.S., McCarty K.S. The correlation of histologic changes in the human breast with the menstrual cycle. American Journal of Pathology 1981, 104(July (1)):23-34.
8. Suzuki R., Atherton A.J., O'Hare M.J., Entwistle A., Lakhani S.R., Clarke C. Proliferation and differentiation in the human breast during pregnancy. Differentiation 2000, 66(October (2-3)):106-115.
9. Deome K.B., Faulkin L.J., Bern H.A., Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Research 1959, 19(June (5)):515-520.
10. Kordon E.C., Smith G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998, 125(May (10)):1921-1930.
11. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439(February (7079)):993-997.
12. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., et al. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439(January (7072)):84-88.
13. Van Keymeulen A., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479(November (7372)):189-193.
14. Tsai Y.C., Lu Y., Nichols P.W., Zlotnikov G., Jones P.A., Smith H.S. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Research 1996, 56(January (2)):402-404.
15. Outzen H.C., Custer R.P. Growth of human normal and neoplastic mammary tissues in the cleared mammary fat pad of the nude mouse. Journal of the National Cancer Institute 1975, 55(December (6)):1461-1466.
16. Sheffield L.G., Welsch C.W. Transplantation of human breast epithelia to mammary-gland-free fat-pads of athymic nude mice: influence of mammotrophic hormones on growth of breast epithelia. International Journal of Cancer 1988, 41(May (5)):713-719.
17. Eirew P., Stingl J., Eaves C.J. Quantitation of human mammary epithelial stem cells with in vivo regenerative properties using a subrenal capsule xenotransplantation assay. Nature Protocols 2010, 5(December (12)):1945-1956.
18. Eirew P., Stingl J., Raouf A., Turashvili G., Aparicio S., Emerman J.T., et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nature Medicine 2008, 14(December (12)):1384-1389.
19. Stingl J., Eaves C.J., Kuusk U., Emerman J.T. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 1998, 63(August (4)):201-213.
20. Stingl J., Eaves C.J., Zandieh I., Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Research and Treatment 2001, 67(May (2)):93-109.
21. Stingl J., Raouf A., Eirew P., Eaves C.J. Deciphering the mammary epithelial cell hierarchy. Cell Cycle 2006, 5(July (14)):1519-1522.
22. Raouf A., Zhao Y., To K., Stingl J., Delaney A., Barbara M., et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008, 3(July (1)):109-118.
23. Stirling J.W., Chandler J.A. The fine structure of ducts and subareolar ducts in the resting gland of the female breast. Virchows Archiv A, Pathological Anatomy and Histology 1977, 373(March (2)):119-132.
24. Stirling J.W., Chandler J.A. The fine structure of the normal, resting terminal ductal-lobular unit of the female breast. Virchows Archiv A, Pathological Anatomy and Histology 1976, 372(December (3)):205-226.
25. Buono K.D., Robinson G.W., Martin C., Shi S., Stanley P., Tanigaki K., et al. The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Developmental Biology 2006, 293(May (2)):565-580.
26. Raafat A., Lawson S., Bargo S., Klauzinska M., Strizzi L., Goldhar A.S., et al. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene 2009, 28(January (2)):219-230.
27. Raafat A., Goldhar A.S., Klauzinska M., Xu K., Amirjazil I., McCurdy D., et al. Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland. Journal of Cellular Physiology 2011, 226(July (7)):1940-1952.
28. Bocchinfuso W.P., Korach K.S. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. Journal of Mammary Gland Biology and Neoplasia 1997, 2(October (4)):323-334.
29. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 1996;51:159-186; discussion 86-88.
30. Humphreys R.C., Lydon J., O'Malley B.W., Rosen J.M. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Molecular Endocrinology 1997, 11(June (6)):801-811.
31. Humphreys R.C., Lydon J.P., O'Malley B.W., Rosen J.M. Use of PRKO mice to study the role of progesterone in mammary gland development. Journal of Mammary Gland Biology and Neoplasia 1997, 2(October (4)):343-354.
32. Ruan W., Monaco M.E., Kleinberg D.L. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 2005, 146(March (3)):1170-1178.
33. Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Research 2002, 4(5):197-201.
34. Korenman S.G. The endocrinology of the abnormal male breast. Annals of the New York Academy of Sciences 1986, 464:400-408.
35. Bembo S.A., Carlson H.E. Gynecomastia: its features, and when and how to treat it. Cleveland Clinic Journal of Medicine 2004, 71(June (6)):511-517.
36. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., et al. Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 2007, 87(July (3)):905-931.
37. Toft D., Gorski J. A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proceedings of the National Academy of Sciences of the United States of America 1966, 55(June (6)):1574-1581.
38. Walter P., Green S., Greene G., Krust A., Bornert J.M., Jeltsch J.M., et al. Cloning of the human estrogen receptor cDNA. Proceedings of the National Academy of Sciences of the United States of America 1985, 82(December (23)):7889-7893.
39. Speirs V., Skliris G.P., Burdall S.E., Carder P.J. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. Journal of Clinical Pathology 2002, 55(May (5)):371-374.
40. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. Journal of Clinical Endocrinology and Metabolism 1997, 82(December (12)):4258-4265.
41. Clarke R.B., Howell A., Potten C.S., Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Research 1997, 57(November (22)):4987-4991.
42. Russo J., Ao X., Grill C., Russo I.H. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Research and Treatment 1999, 53(February (3)):217-227.
43. Petersen O.W., Hoyer P.E., van Deurs B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Research 1987, 47(November (21)):5748-5751.
44. Clarke C.L., Sutherland R.L. Progestin regulation of cellular proliferation. Endocrine Reviews 1990, 11(May (2)):266-301.
45. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Molecular Endocrinology 1993, 7(October (10)):1244-1255.
46. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry 2002, 277(February (7)):5209-5218.
47. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 1995, 9(September (18)):2266-2278.
48. Brisken C., Park S., Vass T., Lydon J.P., O'Malley B.W., Weinberg R.A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(April (9)):5076-5081.
49. Saji S., Jensen E.V., Nilsson S., Rylander T., Warner M., Gustafsson J.A. Estrogen receptors alpha and beta in the rodent mammary gland. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(January (1)):337-342.
50. Schramek D., Leibbrandt A., Sigl V., Kenner L., Pospisilik J.A., Lee H.J., et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010, 468(November (7320)):98-102.
51. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, et al. Progesterone induces adult mammary stem cell expansion. Nature 2010; 10;465 June (7299):803-807.
52. Bertone P., Stolc V., Royce T.E., Rozowsky J.S., Urban A.E., Zhu X., et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004, 306(December (5705)):2242-2246.
53. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes and Development 2011:15;25 September (18):1915-1927.
54. Nana-Sinkam S.P., Croce C.M. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Molecular Oncology 2011, 5(December (6)):483-491.
55. Garzon R., Croce C.M. MicroRNAs and cancer: introduction. Seminars in Oncology 2011, 38(December (6)):721-723.
56. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annual Review of Medicine 2009, 60:167-179.
57. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 2009, 10(October (10)):704-714.
58. Avril-Sassen S., Goldstein L.D., Stingl J., Blenkiron C., Le Quesne J., Spiteri I., et al. Characterisation of microRNA expression in post-natal mouse mammary gland development. BMC Genomics 2009, 10:548.
59. Ucar A., Vafaizadeh V., Jarry H., Fiedler J., Klemmt P.A., Thum T., et al. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nature Genetics 2010, 42(December (12)):1101-1108.
60. Greene S.B., Gunaratne P.H., Hammond S.M., Rosen J.M. A putative role for microRNA-205 in mammary epithelial cell progenitors. Journal of Cell Science 2010, 123(February (Pt 4)):606-618.
61. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(February (4)):629-641.
62. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. 43 September (6):. Molecules and Cells 2011, 43(September (6)):904-914.
63. Berteaux N., Lottin S., Monte D., Pinte S., Quatannens B., Coll J., et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. Journal of Biological Chemistry 2005, 280(August (33)):29625-29636.
64. Lottin S., Adriaenssens E., Berteaux N., Lepretre A., Vilain M.O., Denhez E., et al. The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events. European Journal of Cancer 2005, 41(January (1)):168-177.
65. Berteaux N., Lottin S., Adriaenssens E., Van Coppenolle F., Leroy X., Coll J., et al. Hormonal regulation of H19 gene expression in prostate epithelial cells. Journal of Endocrinology 2004, 183(October (1)):69-78.
66. Guffanti A., Iacono M., Pelucchi P., Kim N., Solda G., Croft L.J., et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009, 10:163.
67. Lin R., Roychowdhury-Saha M., Black C., Watt A.T., Marcusson E.G., Freier S.M., et al. Control of RNA processing by a large non-coding RNA over-expressed in carcinomas. FEBS Letters 2011, 585(February (4)):671-676.
68. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(September (39)):8031-8041.
69. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S.M. The product of the H19 gene may function as an RNA. Molecular and Cellular Biology 1990, 10(January (1)):28-36.
70. Brown C.J., Ballabio A., Rupert J.L., Lafreniere R.G., Grompe M., Tonlorenzi R., et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349(January (6304)):38-44.
71. Cai X., Cullen B.R. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007, 13(March (3)):313-316.
72. Tsang W.P., Ng E.K., Ng S.S., Jin H., Yu J., Sung J.J., et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2009, 31(March (3)):350-358.
73. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(March (5)):646-674.
74. Karakosta A., Golias C., Charalabopoulos A., Peschos D., Batistatou A., Charalabopoulos K. Genetic models of human cancer as a multistep process Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. Journal of Experimental and Clinical Cancer Research 2005, 24(December (4)):505-514.
75. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(January (1)):57-70.
76. Maekawa M., Yamaguchi K., Nakamura T., Shibukawa R., Kodanaka I., Ichisaka T., et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011, 474(June (7350):):225-229.
77. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(April (7)):3983-3988.
78. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1(November (5)):555-567.
79. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Medicine 2009, 15(August (8)):907-913.
80. Molyneux G., Geyer F.C., Magnay F.A., McCarthy A., Kendrick H., Natrajan R., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010, 7(September (3)):403-417.
81. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146(August (4)):633-644.
82. Fillmore C.M., Gupta P.B., Rudnick J.A., Caballero S., Keller P.J., Lander E.S., et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(December (50)):21737-21742.